Diagnostic accuracy of tumor markers CYFRA21-1 and CA125 in the differential diagnosis of ascites

Anticancer Research

Volumn 35, Issue 10, 2015, Pages 5655-5660

  Trapé, Jaume ^a   Gurt, Gabriel ^b   Franquesa, Josefina ^a   Montesinos, Jesús ^a   Arnau, Anna ^a   Sala, Maria ^a   Sant, Francesc ^a   Casado, Esther ^a   Ordeig, Josep Maria ^a   Bergos, Carmen ^a   Vida, Francesc ^a   Sort, Pau ^a   Isava, Álvaro ^a   González, Montserrat ^a   Molina, Rafael ^c  

^a Althai Healthcare University Network of Manresa   (Spain)

^b UNIVERSITY OF VIC CENTRAL UNIVERSITY OF CATALONIA   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

Ascitic fluid; CA125; CYFRA 21 1; Differential diagnosis; Malignant effusion

Indexed keywords

CA 125 ANTIGEN; CYTOKERATIN 19 SOLUBLE FRAGMENT; TUMOR MARKER; UNCLASSIFIED DRUG; ANTIGEN CYFRA21.1; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19; TUMOR ANTIGEN;

ADULT; AGED; ANTIGEN BLOOD LEVEL; ARTICLE; ASCITES FLUID LEVEL; BLOOD LEVEL; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT ASCITES; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; ASCITES; CANCER STAGING; COMPLICATION; FOLLOW UP; METABOLISM; MIDDLE AGED; NEOPLASM; PATHOLOGY; PLEURAL EFFUSION, MALIGNANT; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; ASCITES; BIOMARKERS, TUMOR; CA-125 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KERATIN-19; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS; PLEURAL EFFUSION, MALIGNANT; PROGNOSIS; ROC CURVE;

EID: 84942794560     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Motherby H, Nadjari B, Friegel P, Kohaus J, Ramp U and Böcking A: Diagnostic accuracy of effusion cytology. Diagn Cytopathol 20: 350-357, 1999.
2. Liang QL, Shi HZ, Qin XJ, Liang XD, Jiang J and Yang HB: Diagnostic accuracy of tumour markers for malignant pleural effusion: a meta-analysis. Thorax 63: 35-41, 2008.
3. Kemer T, Ormen M, Kuralay F, Pehlivan M, Unsal B and Tankurt E: Diagnostic usefulness of carbohydrate antigen-125 in cancerous and noncancerous peritoneal effusions. Tohoku J Exp Med 205: 11-18, 2005.
4. Hunter VJ, Weinberg JB, Haney AF, Soper JT, Lavin P, Metsch L, Knapp RC and Bast RC Jr: CA125 in peritoneal fluid and serum from patients with benign gynecologic conditions and ovarian cancer. Gynecol Oncol 36: 161-165, 1990.
5. Miédougé M, Rouzaud P, Salama G, Pujazon G, Vincent C, Mauduyt MA, ReyreJ Carles P and Srre G: Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions. Br J Cancer 81: 1059-1061, 1999.
6. Porcel JM, Vives M, Esquerda A, Salud A, Perez B and Rodriguez-Panadero F: Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid forthe differential diagnosis of benign and malignant effusions: Chest 126: 1757-1763, 2004.
7. Li CS, Cheng BC, Ge W and Gao JF: Clinical value of CYFRA21-1, NSE, CA15-3, CA19-9 and CA125 assay in the elderly patients with pleural effusions. Int J Clin Pract 61: 444-448, 2007.
8. Salama G, Miédougé M, Rouzaud P, Mauduyt MA, Pujazon MC, Vincent C, Carles P and Serre G: Evaluation of pleural CYFRA 21-1 and carcinoembryonic antigen in the diagnosis of malignant pleural effusions. Br J Cancer 77: 472-476, 1998.
9. Tuzun Y, Yilmaz S, Dursun M, Canoruc F, Celik Y, Cil T and Boyraz T: How to increase the diagnostic value of malignancyrelated ascites: discriminative ability of the ascitic tumour markers. J Int Med Res 37: 87-95, 2009.
10. Trapé J, Molina R and Sant F: Clinical evaluation of the simultaneous determination of tumor markers in fluid and serum and their ratio in the differential diagnosis of serous effusions. Tumour Biol 25: 276-281, 2004.
11. Molina R, Bosch X, Auge JM, Filella X, Escudero JM, Molina V, Solé M and López-Soto A: Utility of serum tumor markers as an aid in the differential diagnosis of patients with clinical suspicion of cancer and in patients with cancer of unknown primary site. Tumour Biol 33: 463-474, 2012.
12. Bedioui H, Ksantini R, Nouira K, Mekni A, Daghfous A, Chebbi F, Rebai W, Fteriche F, Jouini M, Kacem M, Ben Mami N, Filali A and Bensafta Z: Role of laparoscopic surgery in the etiologic diagnosis of exudative ascites: a prospective study of 90 cases. Gastroenterol Clin Biol 31: 1146-1149, 2007.
13. Gulyás M, Kaposi AD, Elek G, Szollár LG and Hjerpe A: Value of carcinoembryonic antigen (CEA) and cholesterol assays of ascitic fluid in cases of inconclusive cytology. J Clin Pathol 54: 831-835, 2001.
14. Sari R, Yildirim B, Sevinc A, Bahceci F and Hilmioglu F: The importance of serum and ascites fluid alpha-fetoprotein, carcinoembryonic antigen, CA19-9, and CA15-3 levels in differential diagnosis of ascites etiology. Hepatogastroenterology 48: 1616-1621, 2001.
15. Cascinu S, Del Ferro E, Barbanti I, Ligi M, Fedeli A and Catalano G: Tumor markers in the diagnosis of malignant serous effusions. Am J Clin Oncol 20: 247-250, 1997.
16. Kucukgoz Gulec U, Paydas S, Guzel AB, Buyukkurt S, Seydaoglu G and Vardar MA: Comparative analysis of CA125, ferritin, beta-2 microglobulin, lactic dehydrogenase levels in serum and peritoneal fluid in patients with ovarian neoplasia. Med Oncol 29: 2937-2943 2012.
17. Kalantri Y, Naik G, Joshi SP, Jain A, Phatak S, Chavan R, Hemvani N and Chitnis DS: Role of cancer antigen-125 from pleural and ascitic fluid samples in non malignant conditions. Indian J Med Res 125: 25-30, 2007.
18. Amaral VF, Ferriani RA, Sá MF, Nogueira AA, Rosa e Silva JC, Rosa e Silva AC and Moura MD: Positive correlation between serum and peritoneal fluid CA-125 levels in women with pelvic endometriosis. Sao Paulo Med J 124: 223-227, 2006.
19. Chechlinska M, Kaminska J, Markowska J, Kramar A and Steffen J: Peritoneal fluid cytokines and the differential diagnosis of benign and malignant ovarian tumors and residual/recurrent disease examination. Int J Biol Markers 22: 172-180, 2007.
20. Zeillemaker AM, Verbrugh HA, Hoynck van Papendrecht AA and Leguit P: CA125 secretion by peritoneal mesothelial cells. J Clin Pathol 47: 263-265, 1994.
21. Trapé J, Molina R, Sant F, Montesinos J, Arnau A, Franquesa J, Blavia R,Martín E, Marquilles E, Perich D, Pérez C, Roca JM, Doménech M, López J and Badal JM: Diagnostic accuracy of tumour markers in serous effusions: a validation study. Tumour Biol 33: 1661-1668, 2012.
22. Harłozińska A, Bar JK, Gawlikowski W, Richter R and Cisło M: CA125 and carcinoembryonic antigen levels in cyst fluid, ascites and serum of patients with ovarian neoplasms. Ann Chir Gynaecol 80: 368-375, 1991.
23. Molina R, Filella X, Bruix J, Mengual P, Bosch J, Calvet X, Jo J and Ballesta AM: Cancer antigen 125 in serum and ascitic fluid of patients with liver diseases. Clin Chem 37: 1379-1383, 1991.
24. Trapé J, Filella X, Alsina-Donadeu M, Juan-Pereira L, Bosch-Ferrer , Rigo-Bonnin R; Oncology Section of the Catalan Association of Clinical Laboratory Science: Increased plasma concentrations of tumour markers in the absence of neoplasia. Clin Chem Lab Med 49: 1605-1620, 2011.